HR 2241 sets a funding limit of $3,503,000 for the U.S. Department of Agriculture's Hazardous Materials Management program during fiscal year 2024. This bill directly restricts the amount of money the USDA can spend on managing hazardous materials under this specific program. It prevents the program from using funds exceeding this cap, applying only to the designated hazardous materials management activities within the USDA for that fiscal year.
This bill limits FY2024 funding for the Food and Drug Administration (FDA) Innovation Account, which the FDA uses to implement provisions of the 21st Century Cures Act relating to the development of medical products.
HR 2296 sets a spending limit of $11,788,000 for building and facility projects at the Food and Drug Administration (FDA) and an unspecified "Related Agency" during fiscal year 2024. This bill directly restricts the budget available for infrastructure improvements at these two entities, capping all allocated funds for this purpose. The provision applies to all existing and future funding designated for these specific projects in the 2024 budget cycle. It does not alter FDA operations or regulations, only the financial allocation for physical facilities.
This bill sets a spending cap of $5.58 billion for the Food and Drug Administration (FDA) and related agencies within the Department of Health and Human Services (HHS) for fiscal year 2024. It directly affects the FDA's budget authority by restricting the total funds it can access during the fiscal year. The key provision is a hard limit on available funds, preventing the use of any amount exceeding $5,584,965,000. This is a straightforward budgetary restriction with no additional policy mechanisms or program changes.
Resident Physician Shortage Reduction Act of 2023 This bill increases the number of residency positions eligible for graduate medical education payments under Medicare for qualifying hospitals, including hospitals in rural areas and health professional shortage areas. Current law provides for an increase of up to 200 positions per fiscal year beginning in FY2023, with a total increase of 1,000 positions; each hospital may receive up to 25 additional positions. Current law also provides for an additional increase of up to 200 positions for FY2026, with at least 100 of these positions for psychiatry or related specialties; each hospital may receive up to 10 additional positions. The bill provides for an additional increase of 2,000 positions per fiscal year from FY2025-FY2031; during this period, each hospital may receive up to 75 additional positions in total under the bill and current law. Additionally, one-third of the positions that are made available under the bill must be allocated to hospitals that are already operating above applicable resident limits. The bill also requires the Government Accountability Office to report on strategies to increase the diversity of the health professional workforce, including with respect to representation from rural, low-income, and minority communities.
The Safe Students Act (HR 2502) repeals the Gun-Free School Zones Act of 1990, which had prohibited possessing firearms in federally designated school zones under federal law. It also amends related sections of Title 18 (U.S. Code) to remove references to the repealed law and adjust section numbering. This bill does not establish a new federal rule for school zones; it solely eliminates the existing federal prohibition on firearms in school zones. The repeal means the federal government would no longer enforce this specific ban, though state laws may continue to regulate firearms in schools.
HR 1581, the America Works Act of 2023, modifies work requirement exemptions for the Supplemental Nutrition Assistance Program (SNAP). It expands direct exemptions to include individuals medically certified as unfit for work, parents or caregivers of children under 7, and pregnant women, while removing a specific enforcement clause (Section 6(o)(4)(A)(ii)). The bill adjusts existing exemption rules to clarify that certain exemptions apply retroactively to cases beginning before the bill's enactment date. These changes directly affect SNAP recipients who would otherwise face work requirements under federal law.
HR 1768, the NIH Reform Act, reorganizes the National Institutes of Health (NIH) by splitting the existing "National Institute of Allergy and Infectious Diseases" into three distinct institutes: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases. The bill updates titles, responsibilities, and leadership structures in the Public Health Service Act, including requiring presidential appointments with Senate confirmation for directors of the new institutes, each serving 5-year terms (with one possible reappointment). It mandates a transition period where the NIH Director oversees the new institutes until their directors are appointed, and updates all references to the former institute in federal law. This change directly affects NIH’s internal structure, leadership appointments, and administrative documentation, without altering research funding or policy priorities.
This bill bans the manufacture, processing, use, and distribution of commercial asbestos (including specific fiber types like chrysotile and crocidolite) in the U.S. starting one year after enactment, directly affecting manufacturers, processors, and distributors of these materials. It includes a two-year exception for the chlor-alkali industry to continue using asbestos in diaphragm manufacturing for chlorine production. The President may grant limited, renewable 3-year exemptions for national security reasons, requiring public notice except in rare security-sensitive cases. Additionally, it mandates the EPA and HHS to develop public education resources about asbestos health risks and mitigation options.
S 1098, the Global Health, Empowerment and Rights Act, changes U.S. aid rules for foreign nongovernmental organizations (NGOs) receiving funding under the Foreign Assistance Act. It removes eligibility barriers for these NGOs if they provide health services (like counseling) using their own funds, as long as those services comply with local laws and would be legal in the U.S. It also eliminates extra restrictions on how foreign NGOs can use non-U.S. government funds for advocacy or lobbying, making these rules the same as those applied to U.S. NGOs receiving similar aid. This directly affects foreign health-focused NGOs working in international development and rights advocacy.
The ALIGN Act (S 1117) permanently allows businesses to immediately deduct the full cost of qualified property (like equipment or machinery) purchased and placed in service after September 27, 2017, instead of depreciating it over time. This tax provision directly affects businesses that invest in qualifying assets, reducing their taxable income in the year of purchase. The bill amends the Internal Revenue Code to set a 100% "applicable percentage" for these deductions, making the change permanent. Conforming updates to related tax code sections ensure the provision works with existing rules, effective as if included in prior legislation.
This bill (S 1159) extends compliance timelines for small lenders under the Equal Credit Opportunity Act. It requires the Bureau to grant a 3-year period for lenders to meet new data reporting rules, followed by a 2-year safe harbor where lenders aren't penalized for non-compliance during that time. The bill defines "small business" as entities with under $1 million in annual revenue and "financial institution" as lenders originating at least 500 small business loans annually over the prior two years. It directly affects small lenders (those meeting the 500-loan threshold) and small businesses (under $1M revenue), reducing immediate regulatory pressure through phased implementation.
